Concepedia

Jennifer Sherman

JS

Statistics

Publications

6

Citations

551

H-Index

6

Active since

1993

Affiliations

Alnylam Pharmaceuticals (United States)(Current)

Boston University

Jennifer Sherman is an author at Alnylam Pharmaceuticals (United States) specializing in life sciences, molecular biology, and molecular oncology.

Publications per year

1993–2012

6

Publications

6

A rapid two-step method for isolation of functional primary mouse hepatocytes: cell characterization and asialoglycoprotein receptor based assay development

Mariano Severgnini, Jennifer Sherman, Alfica Sehgal et al. · Cytotechnology · 2011 · 173 citations

Life Sciences, Molecular Biology, Hepatology +11

Homozygous loss of the interferon genes defines the critical region on 9p that is deleted in lung cancers.

Olufunmilayo I. Olopade, Dorothy L. Buchhagen, Kathleen Malik et al. · PubMed · 1993 · 144 citations

Life Sciences, Genetics, Oncology +12

Impact of CUX2 on the Female Mouse Liver Transcriptome: Activation of Female-Biased Genes and Repression of Male-Biased Genes

Tara L. Conforto, Yijing Zhang, Jennifer Sherman et al. · Molecular and Cellular Biology · 2012 · 82 citations · Full text

Life Sciences, Genetics, Molecular Biology +16

Stimulus and cell-specific expression of C-X-C and C-C chemokines by pulmonary stromal cell populations

Nicholas W. Lukacs, Steven L. Kunkel, Ron Allen et al. · American Journal of Physiology-Lung Cellular and Molecular Physiology · 1995 · 76 citations

Life Sciences, Cell Biology, Immunology +13

Antiproliferative small-molecule inhibitors of transcription factor LSF reveal oncogene addiction to LSF in hepatocellular carcinoma

Trevor J. Grant, Joshua A. Bishop, Lisa M. Christadore et al. · Proceedings of the National Academy of Sciences · 2012 · 46 citations · Full text

Medicine, Oncology, Pharmacology +14

1–5 of 6